Three Seasons Wealth’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$464K Sell
18,514
-44,428
-71% -$1.13M 0.04% 124
2026
Q2
$1.6M Buy
62,942
+19,107
+44% +$452K 0.15% 56
2026
Q1
$991K Buy
43,835
+20,504
+88% +$456K 0.38% 67
2025
Q4
$604K Buy
+23,331
New +$555K 0.06% 91

Other funds holding PCRX

Three Seasons Wealth's PCRX Position: Q3 2026 in Review

Three Seasons Wealth reduced its Pacira BioSciences (PCRX) stake by 71% in Q3 2026, selling an estimated $1.13M and leaving 18,514 shares worth $464K. The position accounts for 0.04% of the portfolio, ranked #124.

Three Seasons Wealth first reported a position in PCRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.6M in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Three Seasons Wealth held 18,514 shares of Pacira BioSciences worth $464K as of Q3 2026.
  • Three Seasons Wealth sold 44,428 Pacira BioSciences shares in Q3 2026, an estimated $1.13M.
  • Pacira BioSciences made up 0.04% of Three Seasons Wealth's portfolio in Q3 2026, its #124 holding.
  • Three Seasons Wealth first reported a position in Pacira BioSciences in Q4 2025 and has held it in 4 quarters since.
  • Three Seasons Wealth's Pacira BioSciences position peaked at $1.6M in Q2 2026.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Three Seasons Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.